The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

PowerShares DWA Healthcare Momentum Portfolio

NYSE: PTH
Last

(U.S.) $47.99

Today's change+0.37 +0.78%
Updated July 27 3:59 PM -4GMT. Delayed by at least 15 minutes.
 

PowerShares DWA Healthcare Momentum Portfolio

NYSE: PTH
Last

(U.S.) $47.99

Today's change+0.37 +0.78%
Updated July 27 3:59 PM -4GMT. Delayed by at least 15 minutes.

PowerShares DWA Healthcare Momentum Portfolio Hits New 100-day High

PowerShares DWA Healthcare Momentum Portfolio closed up Wednesday by (U.S.)$0.37 or 0.78% to (U.S.)$47.99 and setting a new 100-day high. Over the last five days, shares have gained 1.98%, but are down 12.92% for the last year to date. Shares have underperformed the S&P 500 by 29.74% during the last year.

Key company metrics

  • Open(U.S.) $47.75
  • Previous close(U.S.) $47.62
  • High(U.S.) $48.10
  • Low(U.S.) $47.41
  • Bid / Ask(U.S.) $43.20 / (U.S.) $0.00
  • YTD % change-12.92%
  • Volume7,717
  • Average volume (10-day)6,302
  • Average volume (1-month)13,376
  • Average volume (3-month)12,403
  • 52-week range(U.S.) $20.91 to (U.S.) $66.63
  • Beta1.14
  • Trailing P/E5.23×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $9.17
Updated July 27 3:59 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9,666.00%

Based on its net profit margin of 9,666.00%, PowerShares DWA Healthcare Momentum Portfolio is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

    No News Results.

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q2/2015Q4/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 30, 201504/30/2015Oct 31, 201410/31/2014Apr 30, 201404/30/2014Oct 31, 201310/31/2013
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit0000
Total cost of revenue0000
Total operating expense0000
Selling / general / administrative0000
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income0000
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1014-39
Income after tax1014-39
Income tax, total----00
Net income1014-39
Total adjustments to net income--------
Net income before extra. items1014-39
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1014-39
Inc. avail. to common incl. extra. items1014-39
Diluted net income1014-39
Dilution adjustment--------
Diluted weighted average shares4232
Diluted EPS excluding extraordinary itemsvalue per share2.486.69-0.965.20
Dividends per sharevalue per share0.000.000.030.12
Diluted normalized EPSvalue per share2.486.69-0.965.20